DA secures US$ 40.8m series C1 extension round for secondary care

The funds were from participating investors Square Peg and Novo Holdings.

Doctor Anywhere (DA), a Singapore-based tech-led healthcare company, said it raised 40.8 million Series C1 extension round with investors Square Peg and Novo Holdings.

The funds will be used for healthcare innovation and to deepen its presence in secondary care.

"The company is set to intensify efforts on product innovation in building a vertically integrated digital healthcare ecosystem. This ecosystem will cater to the rising demand for comprehensive and connected healthcare solutions that prioritise patient experiences and outcomes," read the statement.

Doctor Anywhere has deployed advanced tech in healthcare such as first online supervised tele-antigen rapid testing (ART) service.